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To adequately treat soft tissue tumors, an accurate initial diagnosis is essential. In this article, we describe
the notable points during initial diagnoses as outlined by the “Clinical Practice Guideline on the Diag-
nosis and Treatment of Soft Tissue Tumors”. Clinical ﬁndings including pain and tumor size, growth
speed, and depth, may be important in the diagnosis. In general, malignant soft tissue tumors tend to be
larger than 5 cm in size, to occur in deep layers, and grow quickly. However, there are many exceptions.
Magnetic resonance images can show characteristics of soft tissue tumors, but most of these are non-
speciﬁc. The most reliable diagnostic procedure is histological examination. Therefore, a biopsy is
mandatory. A core needle biopsy can be performed under local anesthesia at an outpatient clinic without
the need for imaging guidance. In cases with deep-seated tumors, an image-guided biopsy is recom-
mended. Incisional biopsies are also widely used procedures. In an incisional biopsy, the skin incision
should be parallel to the long axis of the extremities. A meticulous hemostasis must be carried out to
prevent post-biopsy hemorrhaging. If adequate hemostasis cannot be achieved, a drain is placed within
the incision or at the closest possible site along the incision. Indications for an excisional biopsy are
limited to superﬁcial soft tissue tumors, less than 3 cm in size, located at a suitable distance from the
nearest vital structure. Furthermore, an excisional biopsy should only be carried out after imaging studies
are complete.
© 2016 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.1. Introduction
In the treatment of soft tissue tumors, the initial diagnosis is the
most important step. The appropriate treatment of any musculo-
skeletal tumor is based on a correct diagnosis. We must distinguish
benign from malignant tumors, and primary from non-
mesenchymal tumors; these tumors may be primary or metasta-
tic in soft tissue. The “Clinical Practice Guideline on the Diagnosis
and Treatment of Soft Tissue Tumors” was published in 2012 [1].
Clinical, radiological, and histological examinations, which are
useful in the diagnosis of soft tissue tumors are described in this
report. In the current article, we describe the essential points in the
diagnosis of soft tissue tumors as emphasized in the report.8th Annual Musculoskeletal
ion, Takamatsu, July 9, 2015.
tion. Published by Elsevier B.V. All2. Clinical ﬁndings
2.1. Incidence
Although precise data have been unknown, incidence may be an
important information in a diagnostic step of soft tissue tumors.
Benign soft tissue tumors frequently encountered in clinical prac-
tices are lipoma and hemangioma [2,3]. Giant cell tumor of tendon
sheath and desmoid-type ﬁbromatosis are also common tumors. In
cases with non-neoplastic lesions conﬁrmed on pathological ex-
amination, nodular fasciitis is the most common condition [4]. The
most common malignant soft tissue tumor is liposarcoma [4,5].
2.2. Pain
Although most soft tissue tumors are painless, in some cases
pain is a clinical symptom. Therefore, information on pain may be a
key point in the diagnosis of soft tissue tumors. Most individuals
with hemangiomas experience periodic episodes of pain. Vascularrights reserved.
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tumor is the soft tissue tumormost typically associatedwith pain. It
occasionally occurs in the subungual area, and is associated with
severe, sharp tenderness and pain. In cases of schwannoma, almost
all patients experience tenderness and a “Tinel-like” sign, but they
rarely feel this pain when they are resting. In other benign soft
tissue tumors such as lipoma, pain is a rare symptom. However,
pain is a symptom of some tumor-like lesions. When a rapidly
growing, painful tumor appears in the superﬁcial layer of the
forearm, nodular fasciitis should be considered. If a rapidly
growing, painful tumor occurs in the deep layer of the buttocks or
extremities, hematoma should be considered. In particular, for in-
dividuals who are taking anticoagulant medications, hematoma
should be included in the differential diagnosis.
In many instances of malignant soft tissue tumors, a painless
mass is a characteristic clinical feature. This may result in delays in
referring the patient to the hospital and also in the diagnosis.
Several histological types of malignant soft tissue tumor occa-
sionally show pain. A malignant peripheral nerve sheath tumor is
one such tumor. It usually arises in individuals with neuroﬁbro-
matosis type 1. Long lasting pain in individuals with neuroﬁbro-
matosis type 1 may be indicative of a malignant change in a
neuroﬁbroma. However, malignant peripheral nerve sheath tumors
without pain are not uncommon. Synovial sarcoma may also be
painful, but pain is not a common symptom [6,7]. In the initial
diagnosis of soft tissue tumors, pain is an important symptom, but
it is not a reliable feature in the differential diagnosis of benign and
malignant soft tissue tumors.2.3. Size
The diameter of most benign soft tissue tumors is less than 5 cm.
Typically, giant cell tumor of tendon sheath, plantar ﬁbromatosis,
and leiomyoma have diameters less than 5 cm in size [8e10].
However, there are exceptions: lipoma, schwannoma, and hem-
angioma occasionally have diameters greater than 5 cm although
they are benign [2]. Furthermore, these 3 types are common soft
tissue tumors. In addition, the diameter of desmoid-type ﬁbroma-
tosis, which is classiﬁed as an intermediate, locally aggressive tu-
mor, is usually greater than 5 cm.
For over 70% of malignant soft tissue tumors reported in Japan,
the size of the tumorwas greater than 5 cm [5]. If the clinical and/or
imaging ﬁndings differ from those of lipoma, hemangioma, or
schwannoma, the possibility of malignancy should be considered
for tumors with diameters greater than 5 cm.2.4. Growth speed
When differentiating between benign and malignant soft tissue
tumors, information regarding the growth speed may be helpful.
Most benign soft tissue tumors grow gradually over several years,
occasionally over 10 years. Malignant soft tissue tumors usually
growwithin severalmonths. However, there are several exceptions.
A typical exception regarding growth speed is nodular fasciitis. It
usually grows rapidly within the space of a week. Nodular fasciitis,
abscess, intramuscular hematoma, and hemangioma can all show
rapid growth within several days, even though they are non-
neoplastic or benign lesions. In contrast, some malignant soft tis-
sue tumors can grow over several years; cases of slow-growing
synovial sarcomas and epithelioid sarcomas have been reported
[7,11]. The following have also occasionally demonstrated slow
growth over a 10-year period: alveolar soft part sarcoma, well-
differentiated liposarcoma (an atypical lipomatous tumor), der-
matoﬁbrosarcoma protuberance, and other low-grademalignancies. Therefore, growth speed is not reliable feature in the
differential diagnosis of benign and malignant tumors.
2.5. Depth
Nodular fasciitis, vascular leiomyoma, ganglion, atheroma,
hemangioma, and lipoma are all common lesions of the subcu-
taneous layer (Fig. 1). All of these lesions are non-neoplastic or
benign soft tissue tumors. Therefore, most superﬁcial lesions that
do not penetrate the fascia are benign. However, it is important to
note that hemangioma and lipoma occasionally occur in layers
deeper than the fascia.
Most malignant soft tissue tumors occur in the deep layer.
However, dermatoﬁbrosarcoma protuberans, epithelioid sarcoma,
and myxoﬁbrosarcoma occur in the superﬁcial layer. Characteris-
tically, epithelioid sarcomas are usually associated with ulcers or
skin erosions (Fig. 2). We should be aware that a superﬁcial lesion
could be malignant.
3. Imaging studies
3.1. Radiograph
Several types of soft tissue tumors show characteristic features.
Hemangiomas occasionally show well-demarcated calciﬁcation
secondary to phleboliths or metaplastic ossiﬁcation [12] (Fig. 3).
This may be a diagnostic ﬁnding in soft tissue hemangiomas,
especially in the cavernous subtype. Cortical thickening or a saucer-
like depression in the bone adjacent to the hemangioma is a
common ﬁnding. In lipoma, dense fat with a relatively sharp
margin is usually observed in radiographs. Bone erosion or cystic
changes associated with giant cell tumor of tendon sheath and
diffuse-type giant cell tumor are common ﬁndings. In non-
neoplastic soft tissue lesions, synovial chondromatosis might
show erosion or cystic changes of the bones around the joint.
Myositis ossiﬁcans usually shows a peripheral mineralization
within the lesion [13].
Irregular or punctate mineralization in malignant soft tissue
sarcomas such as synovial sarcoma is awell-known ﬁnding, but it is
not common. Occasionally, soft tissue osteosarcoma shows irreg-
ular mineralization [14]. When the bone adjacent to a soft tissue
tumor shows destructive or inﬁltrative changes, the tumor should
be considered to be malignant.
3.2. Ultrasonography
Ultrasonography is an easy and useful tool for detecting, and
evaluating the depth of soft tissue tumors. A relationship between
the lesions and the structures around them, particularly during
motion of the extremities, has beenwell demonstrated. For a lesion
in the subungual area accompanied by severe pain, ultrasono-
graphic examination may contribute to the diagnosis of glomus
tumor [15] (Fig. 4). Ultrasonography is also useful as an imaging
guide on core needle biopsy, as described later.
3.3. Magnetic resonance imaging
Several types of soft tissue tumors show characteristic features.
In both lipoma and well-differentiated liposarcoma, T-1 and T-2
weighted MR images show high signals. The high signal intensity
areas are homogenous in lipoma (Fig. 5), but an irregular mixture of
low signal intensity areas is common in well-differentiated lip-
osarcoma (Fig. 6). A split fat sign or target sign on T-2 weighted
images is a well-known characteristic of schwannoma [16] (Fig. 7).
Lipoma and schwannoma are the most common benign soft tissue
Fig. 1. Magnetic resonance (MR) images of nodular fasciitis (white arrow: left, T-1 weighted image; right, T-2 weighted image). Note the lesion on the fascia.
Fig. 2. Epithelioid sarcoma occurring in the right hand. Ulcer formation on the hand
lesion (left) and disseminated lesions on the forearm (right) were observed.
Fig. 3. Radiograph of hemangioma of the thigh. Within the outline of the tumor (white
arrow head), many areas of calciﬁcation are observed.
Fig. 4. Ultrasonographic image (upper) and T-2 weighted MR image (lower) of a
glomus tumor in the subungual region. On the ultrasonograph, thickening of the
subungual tissue and small hypervascular lesions are observed.
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images is important. For diffuse-type giant cell tumor of soft tissue,
a low signal intensity on both T-1 and T-2 weighted MR images,
reﬂecting a large hemosiderin content, is a key diagnostic point if
the lesions are found within joint spaces (Fig. 8). For ganglion,
bursitis, and lymphangioma, a homogenous low signal intensity on
T-1 weighted images, an extremely high signal intensity on T-2
weighted images, and peripheral enhancement by gadolinium
administration would be diagnostic. Epidermoid cysts (atheroma)
show similar ﬁndings, but the disappearance of subcutaneous fat
between the skin and the lesion is also noted (Fig. 9).
Triple signal intensity is reported as one of the characteristic MR
ﬁnding of synovial sarcoma. In alveolar soft part sarcoma, a rela-
tively high signal intensity on T-1 weighted images, an extremely
high signal intensity on T-2 weighted images, and large ﬂow void
marks within the tumor are considered to be characteristic ﬁndings
[17]. Most other kinds of soft tissue tumors, however, show low- or
iso-signal intensity on T-1 weighted images and high signal in-
tensity on T-2 weighted images (Fig. 10). It should be emphasized
that MR images are not speciﬁc for most types of soft tissue lesions.
Fig. 5. T-1 weighted (left) and T-2 weighted (right) MR images of a lipoma of the thigh. Both images show the homogenously high signal lesion.
Fig. 6. T-1 weighted sagittal (left) and T-2 weighted axial images of a well-differentiated liposarcoma. In both images, signal intensity of the lesion is high, but not homogenous.
Note the partial low signal intensity area within the lesion.
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Histological diagnosis is the most reliable procedure for the
diagnosis of soft tissue tumors. In some instances, a patient's his-
tory, symptoms, and imaging studies provide sufﬁcient information
to guide deﬁnitive treatment. However, in most cases, a histological
examination of a biopsy specimen is necessary. A biopsy, although
technically simple, must be conducted in a thoughtful manner to
accurately obtain an appropriate tissue sample, while also avoiding
complications. There are several types of biopsy procedures in
current use. Needle biopsies and incisional biopsies are the
generally recommended procedures. An excisional biopsy is
allowed under the limited conditions described below.3.5. Core needle biopsy
Core needle biopsy is a widely used procedure. In most cir-
cumstances, it can be performed under local anesthesia at an
outpatient clinic without image-guidance [18]. In cases of deep or
non-palpable lesions, sonographic guidance, a simple and non-
invasive imaging method, can be employed. Computerized
tomography-guided needle biopsy is another useful method. In a
core needle biopsy, tumor cell contamination of the biopsy tract is
limited to the tract of the needle. A small contamination areameans
that an appropriate surgical margin can be obtained in the subse-
quent surgery. There are several points to note when considering a
core needle biopsy. In small lesions, the needle should not pass
Fig. 7. A target sign on T-2 weighted MR image in a case of schwannoma of the popliteal region. On the T-1 weighted MR image (left), the lesion (arrow) has a homogenously low
signal. On the T-2 weighted MR image (right), the periphery of the lesion displays a high signal intensity, but the center area shows a low signal intensity.
Fig. 8. MR images of a diffuse-type giant cell tumor of the knee joint. On the T-1 weighted image (left), the signal intensity of the lesion is low. On the T-2 weighted image (right),
the solid area of the lesion (white dot line) also shows a low signal intensity adjacent to the high signal area of ﬂuid collection.
Fig. 9. MR images of a case of atheroma. Atheroma typically shows a homogenous low signal intensity on T-1 weighted image (left) and a homogenously high signal intensity on T-2
weighted image (right). Characteristically, subcutaneous fat tissue on the mass disappears.
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surgerymay be the result of tumor dissemination during the needle
biopsy. Usually, a needle biopsy can be performed under a local
anesthesia without any pain. However, in schwannoma, sharp painduring the insertion of the needle is commonly observed. If a
needle biopsy must be performed for a tumor with a “Tinel-like”
sign and/or a split fat sign and target sign on theMR images, regions
without “Tinel-like” sign nor tenderness should be selected as the
Fig. 10. Non-speciﬁc ﬁndings of MR images of a soft tissue tumor. The sarcoma in the adductor longus shows an iso signal intensity on the T-1 weighted image (left) and irregularly
high signal intensity on the T-2 weighted image (right).
Fig. 11. A schematic of a core needle biopsy showing the relationship between the
contour of the tumor and the position of the inserted needle. In an adequate procedure
(left), the needle tip stays within the tumor. In an inadequate procedure, the needle
perforates the deep layer of the tumor inducing dissemination of the tumor.
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the needle should lie within the area of the subsequent surgery.
Therefore, a short needle tract should be identiﬁed. Contamination
of vital structures, including important neurovascular bundles,
should be avoided (Fig. 12). With a deep-seated lesion, an approach
through a single muscle is recommended. An intermuscular
approach may result in the diffuse spread of contaminating tumor
cells around the muscles. The muscle perforated by the needle
should be partially or totally excised during the subsequent surgery.
After the biopsy, compression is recommended to prevent a post-
biopsy subcutaneous hemorrhage. If the tissue obtained is from aFig. 12. A schematic showing adequate (left) and inadequate (right) approaches of a
core needle biopsy in muscle. Tumor cell contamination of a vital structure including
an important neurovascular bundle should be avoided. T, tumor; M, muscle; A, artery;
N, nerve.necrotic area, a histological diagnosis is difﬁcult. Imaging studies
before the biopsy are mandatory to obtain adequate tumor tissue.
Any areas without enhancement by contrast medium administra-
tion on MR images should be avoided as biopsy sites. When the
tissue obtained by the core needle biopsy is inadequate or non-
diagnostic, the procedure can be easily repeated under image-
guidance to obtain a representative sample of the tumor tissue.3.6. Incisional biopsy
An incisional biopsy has several advantages over a core needle
biopsy. A sufﬁcient amount of tissue can be obtained and it is
possible to observe the surface appearance of the tumor. On the
other hand, several disadvantages, or points of note, for an inci-
sional biopsy should also be stressed [19e21]. The most important
point is the direction of the skin incision. It should be on the line of
the subsequent deﬁnitive surgery [20]. Therefore, it should be
parallel to the long axis of the extremities (Fig. 13). The biopsy tract
from the skin incision to the tumor should be as short as possible.
Skin contaminated by tumor cells during the biopsy should be
excised in the deﬁnitive surgery. Contamination of vital structures
including neurovascular bundles should also be avoided.
Diffuse subcutaneous bleeding might occur after an incisional
biopsy; this would affect any surgical treatment, since the area ofFig. 13. A schematic of adequate (left) and inadequate skin incisions in an incisional
biopsy. The incision should be along the line of the subsequent deﬁnitive surgery.
Therefore, it should be parallel to the long axis of the extremities.
Fig. 14. A schematic of the position of the drain after an incisional biopsy. The drain
should be placed within, or near, the incision (left). If the drain is placed further away
(right), tumor cells may spread along the drain root.
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number of careful ligations or coagulations should be done during
the procedure. A hemostatic agentmay be effective in some cases. If
bleeding in the biopsied area cannot be adequately controlled,
insertion of a drain should be considered. The drain should be
inserted within or near the incision. If the drain is placed further
away, tumor cells may spread along the drain root. The width of the
suture should be as narrow as possible (Fig. 14). If the suture is
wide, then a large area of skin will be excised during the deﬁnitive
surgery. If the lesion is deep, an approach through a single muscle is
recommended; the muscle with the biopsy tract should be partially
or totally excised during the subsequent surgery. If the biopsy tract
is intermuscular or if it passes through several muscles, an excision
of several muscles should be considered.3.7. Excisional biopsy
Indications for an excisional biopsy are limited. Since a needle
biopsy is safely possible for tumors larger than 3 cm in diameter, an
excisional biopsy is indicated for a mass less than 3 cm in diameter
(Fig. 15). In an excisional biopsy, the surgical margins are marginal
or intralesional margins. Therefore, an additional wide excision is
mandatory if the pathological diagnosis of the biopsy determines
that the lesion is malignant. Several studies have shown that the
prognosis for malignant soft tissue tumors that are initially treated
by an excisional biopsy, followed by an additional wide excision, is
acceptable [22].
However, additional wide excisions are associated with several
practical problems. The surgical plan for an additional wideFig. 15. A schematic depicting the indications for an excisional biopsy. An excisional
biopsy is indicated for a soft tissue tumor less than 3 cm in diameter, within the su-
perﬁcial layer, located far away from any vital structures. Furthermore, an imaging
study is mandatory before the biopsy takes place.excision may be problematic, as the main primary tumor has
already been excised. Imaging studies prior to the biopsy generate
the most important information for an additional wide excisions. If
a tumor was already excised without any imaging guidance, the
additional wide excision plan should take into account the location
of the biopsy skin incision. Imaging studies carried out after the
biopsy show a tumor shadow or any secondary changes associated
with the biopsy procedure. An excisional biopsy without any im-
aging studies, or where no attention was paid to the surgical
margins, is called an “unplanned excision”. In these unplanned
excisions, tumor remnants are frequently observed [23]. Unfortu-
nately, these unplanned excisions are still performed in outpatient
clinics. It should be stressed that imaging studies prior to an exci-
sional biopsy are essential. Ultrasonographs may provide adequate
information before the biopsy, but for malignant soft tissue tumors,
a single ultrasonographic image along the long axis is not sufﬁcient
for an excisional biopsy.
Furthermore, hematomas or exploration spaces after an exci-
sional biopsy are usually larger than the initial tumor. Additionally,
diffusion of the tumor can occur. Large amounts of non-tumor
tissue around a hematoma that forms after an excisional biopsy
should be excised during the additional wide excision procedure. In
malignant soft tissue tumors accompanied by diffuse subcutaneous
bleeding, an amputation may be indicated as the subsequent
deﬁnitive treatment. Considerable hemostasis, including ligation
and coagulation should be carried out.
An excisional biopsy is indicated for a superﬁcial soft tissue
tumor. In deep-seated tumors, the exploration during the approach
to the tumor is more diffuse than that of superﬁcial tumors. Oc-
casionally, deep-seated tumors are adjacent to vital structures
including important neurovascular bundles. Tumor cell contami-
nation can occur diffusely around neurovascular bundles. Similar to
an incisional biopsy, the skin incision in an excisional biopsy should
be parallel to the long axis of the extremities; any post-biopsy drain
should be placedwithin or near the incision; and a small suture bite
is recommended.Conﬂict of interest
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